GPRA Update CAPT S. Miles Rudd, MD Chief Medical Officer Portland Area October 24, 2013.
Pertussis Kate Goheen March 25, 2009 Weill Cornell Medical College Class of 2010.
Clinical Review Process: An FDA Perspective Karen Midthun, M.D. Deputy Director of Medicine Center for Biologics Evaluation and Research FDA April 15,
Growth and Development. Immunizations Hep B – vomiting., jaundice, cirrhosis, liver cancer, death Diphtheria – sore throat, fever, swollen neck, Tetanus.
Amanda Faulkner, MPH Meningitis and Vaccine Preventable Diseases Branch Centers for Disease Control and Prevention September 25, 2012 Responding to the.
1 Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed (Tdap, ADACEL™) Aventis Pasteur, Ltd. VRBPAC – March 15, 2005 ChrisAnna.
Welcome to Collingswood Middle School
1 Scott Stibitz, Ph.D. Center for Biologics Evaluation and Research (CBER), FDA Bethesda, Maryland FDA Regulation of Bacterial Vaccines.
18% of reactions were in the school setting (McIntyre CL Pediatrics 2005) Data collection over a 2 year time showed majority of reactions occurred.
IMMUNITY IMMYNIZATION IMMUNITY. Active immunity are defenses developed by the body that last many years or even a life time. Active immunity are defenses.
Vaccines
Vaccines H.Sidra Yasin (BIOT 412). Learning objectives What are the Methods to produce the vaccines How we can modify the Vaccines What are the Routs.
